| J3262 | Injection, tocilizumab, 1 mg | 47,590 | $10 | $237.9K |
| J9312 | Injection, rituximab, 10 mg | 3,100 | $60 | $198.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,930 | $10 | $131.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,820 | $30 | $120.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,000 | $1 | $88K |
| J0897 | Injection, denosumab, 1 mg | 3,480 | $20 | $62.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 590 | $90 | $51.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $60 | $17.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 150 | $110 | $17K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 360 | $40 | $16K |